Clinical Trials Insight: 700035799
Phase of Trial: Phase II
Latest Information Update: 30 Jul 2008
At a glance
- Drugs XOMA 629 (Primary)
- Indications Bacterial infections; Impetigo; Skin infections
- Focus Therapeutic Use
- Sponsors XOMA
- 30 Jul 2008 New trial record.
- 24 Jul 2008 Preliminary results are expected in quarter 4 2008, accordiing to a XOMA media release.